The latest -Cancer Cell Therapy Markets -Report By Aarkstore

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 23, 2012 -- Cancer Cell Therapy Markets
http://www.emarketreports.com/reports/Cancer-Cell-Therapy-Markets-183398.html

Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell proliferation. In other circumstances, a variety of therapeutic molecules have been utilized lead the disease cells to perform a specific function that they normally do not. These include small molecules, peptides, proteins, antibodies, anti-sense RNAs and ribozymes. In the case of cell therapy, as the name indicates, treatment is carried out with cells instead of small molecules. In cell therapy, cells are given to the patient as the therapeutic delivery system for a specific disease to achieve therapeutic benefit. The purpose of this TriMark Publications report is to describe the market segment of the cell therapy market aimed specifically at cancer therapy. Moreover, a review of cellular agents that are related to the chemical and cellular constituents of blood or other tissues for cancer care of the patient is addressed in this study. The two most important areas where such agents are used are in the hospital and the clinic. Emphasis is on those companies and products that are actively developing and marketing cell therapeutic agents and supplies for treating cancer patients.
Table of Contents :
1. Overview 8
1.1 Statement of Report 8
1.2 About this Report 8
1.3 Scope of the Report 10
1.4 Objectives 10
1.5 Methodology 10
1.6 Executive Summary 12
2. Introduction to Cancer Biology and the Diagnostic Industry 15
2.1 Cancer 15
2.1.1 The Disease 15
2.1.2 Metastasis 16
2.1.3 Demographics and Statistics of Cancer 16
2.2 The Drivers of the Biotech and Diagnostics Industry 20
2.2.1 Technological Innovation 22
INDEX OF FIGURES

Figure 4.1: Model of CRC Development 63

Figure 4.2: Progression of CRC Development 63
Figure 4.3: ASCO-CAP Guidelines for HER2 Testing in Breast Cancer: Equivocal
Results with IHC 96
INDEX OF TABLES

Table 2.1: Organ-Specific Medicines in Development for Cancer 17
Table 2.2: Leading Sites of New Cancer Cases and Deaths in 2010 in the U.S. by
Sex 18
Table 2.3: Worldwide Number of New Cancer Cases and Deaths by Type of Cancer 18
Table 2.4: Number of New Cancer Cases and Deaths by Region 19
Table 2.5: Cancer-Associated Genes 19
Related Reports:
Cancer Therapeutics Markets
Cancer Vaccines Markets

Cardiac Marker Diagnostic Testing Markets
Cardiac Rhythm Management Devices World Markets

From: Aarkstore Enterprise
Contact: Marketing Team
Mob.No.918149852585/919272852585
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com/
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

Aarkstore Enterprise     cancer     cell therapy     oncology